CRISPR Therapeutics AG
업데이트됨

Crispr consolidates, higher lows but with upward resistance

111
I stopped out on Crispr at 173.50 and since then the stock has consolidated setting higher lows while unable to break through resistance at around 173-173.50. This has had a significant impact on ARK-G which fed off the strong up-moves Crispr has made over the last six months.

It is believed that Crispr is the Apple of the future. Many times over Apple's price moves in the last decade, there were months and even years with little to no upward movement. For many, the buy and hold strategy may be the best approach.
노트
Still working neatly within the wedge. Time to plan for re-entry.

스냅샷

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.